Creosote bush lignans for human disease treatment and prevention: Perspectives on combination therapy  by Gnabre, John et al.
ble at ScienceDirect
Journal of Traditional and Complementary Medicine 5 (2015) 119e126Contents lists availaHOSTED BY
Journal of Traditional and Complementary Medicine
journal homepage: http: / /www.elsevier .com/locate/ j tcmeReview articleCreosote bush lignans for human disease treatment and prevention:
Perspectives on combination therapy
John Gnabre a, Robert Bates b, Ru Chih Huang c, *
a Mal-4 Research Institute, Baltimore, MD, USA
b Department of Chemistry, University of Arizona, Tucson, AZ, USA
c Department of Biology, Johns Hopkins University, Mudd Hall, Baltimore, MD, USAa r t i c l e i n f o
Article history:
Received 25 September 2014
Received in revised form
2 October 2014
Accepted 13 November 2014
Available online 12 March 2015
Keywords:
cancer
creosote bush
lignans
nordihydroguaiaretic acid
viruses* Corresponding author. Department of Biology, Joh
North Charles Street, Baltimore, MD 21218, USA.
E-mail address: rhuang@jhu.edu (R.C. Huang).
Peer review under responsibility of The Center
National Taiwan University.
http://dx.doi.org/10.1016/j.jtcme.2014.11.024
2225-4110/Copyright © 2015, Center for Food and Bioa b s t r a c t
The medicinal properties of the most successful plant in the deserts of the western hemisphere, the
creosote bush (Larrea tridentata), are evidenced by the long traditional usage of the plants by the Native
Americans Indian tribes in Southwestern North America and the Amerindians from South America. The
plant is rich in simple bisphenyl lignans and tricyclic lignans known as cyclolignans. These compounds
are responsible for many of the pharmacological activities of extracts of the plants. Some of these ac-
tivities, namely antiherpes, antioxidant, antifungal, and anti-inﬂammatory, were known a century ago.
Only recently have further studies revealed other crucial activities of the same plant molecules as
powerful agents against human immunodeﬁciency virus, human papillomavirus, cancer, neurodegen-
erative diseases, and symptoms of aging. Molecular mechanisms underlying the antiviral and anticancer
activities have been elucidated and involve the inhibition of SP1 dependent gene transcription. This
review summarizes the recent ﬁndings on creosote bush lignans. We introduce the concept of a cocktail
of safe well-characterized natural products from the creosote bush that would represent a bridge be-
tween oriental herbal medicines and Western drug-based therapies.
Copyright © 2015, Center for Food and Biomolecules, National Taiwan University. Production and hosting
by Elsevier Taiwan LLC. All rights reserved.1. Introduction
Medicine has been intimately associated with human history
since the dawn of civilization. The use of herbal concoctions for
medicinal purposes dates back at least to several millennia BC from
the records of ancient Egyptian, Chinese, Babylonian, Greek, and
Roman cultures.1 To date < 2% of botanical resources have been
exploited for bioactivemolecules. These have resulted in nearly 25%
of all prescription medicines, which underscores the vital impor-
tance of investigating thoroughly the plant kingdom for potential
treatment modalities. Nature is the ﬁrst, and for millions of people,
the only source for medicines. According to reports of the World
Health Organization (WHO), 80% of the world population depends
on herbal medicine for primary health care.2 In spite of scientiﬁcns Hopkins University, 3400
for Food and Biomolecules,
molecules, National Taiwan Univeprogress in organic synthesis and biochemistry over the past cen-
tury, current medicine still relies primarily on drugs isolated from
plants, fungi, marine botanicals, molds, etc. to save countless hu-
man and animal lives. Although some of these molecules have
served as templates for semisynthetic congeners currently in clin-
ical use, what nature designed often cannot be easily duplicated.
Medicinal lignans have aroused the interest of the medical com-
munity only over the past 2 centuries with the discovery of the me-
dicinal properties of the highly cytotoxic compounds podophyllin
and podophylotoxin (Fig. 1). Podophyllin is a resinous powder
extracted primarily from the rhizomes of American Mayapple
(Podophyllum peltatum) and Himalayan Mayapple (Podophyllum
hexandrum or emodi). Podophyllotoxin, also known as podoﬁlox, is
extracted from the roots and rhizomes of several Podophyllum spe-
cies. These compounds are powerful antineoplastic agents.3
Podophyllum-derived compounds, along with other complex
lignans, are part of two important classes of lignans known as
aryltetralin lignans and arylnaphthalene lignans (Fig. 1). Current
efforts are aimed at using these molecules as templates for drug
discovery. Both aryltetralin and arylnaphthalene lignans serve as
lead compounds for drug development as they exhibit a plethora ofrsity. Production and hosting by Elsevier Taiwan LLC. All rights reserved.
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Fig. 1. Major classes of lignans with prototype molecules. The dibenzylbutanes or linear lignans and the cyclolignans are found in most species of Larrea including the creosote bush.
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isolated from the Chinesemock-barberry, Schisandra chinensis (五味
子 wǔ wei zǐ). This plant is the source of numerous benzocy-
clooctadiene lignans that support the uses of the plant extract in
traditional oriental medicine.5 Several classes of lignan are shown
in Fig. 1, where the complexity of the molecules of the other classes
sharply contrasts with the structural simplicity of the dibenzylbu-
tane or linear type lignans found in the creosote bush.2. Distribution and botanical description of the creosote bush
The creosote bush, Larrea tridentata (DC.) Cov., is a desert shrub
also known as gobernadora (meaning lady governor to reﬂect the
shrub's remarkable ability of retaining water by inhibiting, through
its roots, the growth of most nearby plants), hediondilla (Spanish
for little stinker), and guamis. The creosote bush is a widespread
perennial ﬂowering bush thriving in the deserts of the South-
western USA and south through the NewWorld deserts. Its generic
name Larrea honors the Spanish scientist J. A. Hernandez Perez de
Larrea, who ﬁrst described the species.6,7
It is believed that the creosote bush originated in South America
and spread to North America some millennia ago. In some aridregions of southwestern USA, the plant not only thrives as the most
dominant vegetation but has also genetically adapted as evidenced
by genotypes that vary according to regions. The plant grows in all
desert regions, but only the species that grow in South America and
in North America's largest desert (the Chihuahuan) carries two sets
of chromosomes in each cell nucleus. In the Sonoran desert, where
winters are mild and rains fall during both the summer and winter,
the plant has four sets of chromosomes. By contrast, in the Mojave
desert, the smallest and driest desert of the USA, where summers
are very long and hot, the plant is hexaploid.7,8 Whether the
chromosomal variations are in response to the climate of the region
or correlate with the quantity and diversity of the production of
secondary metabolites is unknown. There is considerable phar-
macologic interest in these metabolites, which the plant appears to
use for defense.3. Use in traditional and complementary medicine
The wide range of pharmacological activities ascribed to the
creosote bush is evidenced by the myriad of traditional uses of the
plant extract among various indigenous societies. Pima and Mar-
icopa Indians use the extracts or decoctions of the shrub for a wide
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sexually transmitted diseases, menstrual pain in women, and
snake bites. Other traditional uses of the leaves include treatment
of cold virus infections, inﬂuenza, diabetes, skin sores, arthritis,
sinusitis, gout, anemia, fungal infections, and cancer. Usages of the
plant for antimicrobial properties, women's premenstrual symp-
toms, allergies, autoimmune diseases, and rheumatism are still of
common occurrence in several indigenous cultures. Chaparral tea
(made from creosote bush) is commonly used to treat gallbladder
and kidney stones. A thorough review of the medicinal uses of
creosote bush is available.6 This report may not be exhaustive, as
evermore compounds are discovered from Larrea species and
newer ethnobotanical applications are described.4. Phytochemistry
Lignans are one of the most important classes of natural
products in Larrea species. They include nordihydroguaiaretic
acid (NDGA) and its methylated derivatives. These compounds
were reported to occur in the desert plant several decades ago.9
Later, cyclolignans and furanoid lignans were added to the
list.10 The plant resin has been reported to contain a total of 19
ﬂavonoid aglycones, some ﬂavonoid glycosides, and a large
quantity of essential oils (about 300 volatile compounds) making
up 0.1% of the dry weight and containing 67 nonvolatile com-
pounds.6 Along with these compounds, creosote bush extracts
contain saponins, sapogenins, tannins, sterols, monoterpenes, and
sesquiterpenes. The list of creosote bush ingredients is continu-
ously being updated, as evermore state-of-the-art analytical in-
struments with high-throughput screening are used to study the
plant constituents.5. Lignans
Lignans were ﬁrst deﬁned by Haworth et al11 as dimers of
phenylpropanoid (C6-C3) units linked by the central carbons of
their side chains. The early lists of lignans have been updated by a
compilation of > 350 new lignans discovered since 2005.12 Lignans
are divided into subclasses based on the way the oxygen atom is
incorporated in the skeleton and the cyclization of the molecule.13
Below we list the subclasses for this important class of natural
products. Their chemical structures are depicted in Fig. 1 with
prototype molecules.5.1. Linear lignans (dibenzylbutanes, NDGA derivatives)
This class consists of NDGA and its derivatives. NDGA, one of the
major constituents of creosote bush, makes up to 50% of the resin
covering the surface of the leaves. From 5 g to 10 g of NDGA can be
extracted from 100 g of the dry leaves. This exceptional yield ac-
counts for the use of creosote bush as a primary commercial source
for NDGA. NDGA is accompanied by many O-methylated de-
rivatives, such as guaiaretic acid, which is the main constituent of
the heartwood resin of Guniacum oﬁcinule.11,145.2. Dibenzylbutyrolactones
The common wood constituent matairesinol is a dibenzylbu-
tyrolactone. This subtype has not been reported in creosote bush.
Lactone-containing molecules exhibit a greater antitumor potency.
However, lactones can be easily metabolized in the gastrointestinal
(GI) tract by esterases, which deactivate the molecule.5.3. Cyclolignans
Norisoguaiacin and its 30-methyl derivative are examples of
cyclolignans. These two lignans occur in creosote bush in< 0.1% and
were found to be signiﬁcantly more active in an anti-human im-
munodeﬁciency virus (anti-HIV) assay than NDGA and its methyl-
ated derivatives.15
5.4. Tetrahydrofurans
Substituted tetrahydrofuran lignans can be categorized into
three subtypes: 2,5-diaryltetrahydrofurans, 2-aryl-4-
benzyltetrahydrofurans, and 3,4-dibenzyltetrahydrofurans.12
5.5. Furofurans
This is one of the major subclasses of the lignan family. These
lignans exhibit a wide range of biological functions including
antitumor activity,16 and have been reviewed.12
5.6. Dibenzocyclooctadienes
Gomisin N was isolated from Schisandra chinensis (五味子 wǔ
wei zǐ). It is the most active dibenzocyclooctadiene, with anti-
proliferative activity in human colorectal carcinoma.17 Schisandra
species are rich in benzocyclooctadiene lignans with a plethora of
biological activities. Their pharmacology has been the subject of an
exhaustive review.5
5.7. Neolignans
Classic lignans are phenylpropane dimers linked by a bond be-
tween positions C8 and C80, while neolignans are those dimers
whose coupling patterns differ from such a C8eC80 linkage. Ex-
amples include magnolol and honokiol, principal constituents of
the Asian medicinal plant Magnolia obovata. A number of phar-
macological activities such as sedation, antistress, anticancer, anti-
inﬂammatory, and hepatoprotective effects associated with the
magnolia plant extract are due in part to these two neolignans.18
With the discovery of new structures, neolignans have been
divided into 15 subtypes, showing the diversity of compounds in
this class. Some of the constituents include biphenyl derivatives,
eupomatenoid, benzofurans, burchellin benzofurans, bicy-
clooctanes, and futoenones.12 It is beyond the scope of this review
to cover these subclasses although they are clinically relevant in the
ﬁght against human diseases such as cancer, HIV/AIDS, and
neurodegenerative diseases. In this review, we will focus on the
simple NDGA type diphenylbutane lignans of creosote bush.
6. Pharmacological activities of creosote bush lignans
6.1. NDGA, the major metabolite and potent antioxidant
The biology and chemistry of the constituents of Larrea species
including its major metabolite NDGA have been the subjects of
excellent reviews.9,19 Although useful as an antioxidant, NDGA
possesses an inherent toxicity and was withdrawn from use by the
United States Food and Drug Administration in 1968 for causing
cystic nephropathy in rats. High doses of the plant extract were
shown to cause hepatotoxicity, dermatitis, biliary toxicity, and
other ailments, in part as a result of NDGA effects.20 Indeed, NDGA
possesses intrinsic hepatoxicity as the molecule is metabolized by
the liver into O-methyl and glutathione conjugates.20 This toxicity
is virtually eliminatedwhen NDGA is O-methylated. For this review,
we present the various ﬁndings on the less toxic methylated
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able antiviral and anticancer activities.
6.2. Methylated derivatives of NDGA
6.2.1. Antiviral activities
Methylated derivatives of NDGA, such as 30-O-methyl-NDGA
(Mal-4), and other lignans with various degrees of O-methylation,
were ﬁrst shown to possess activity against HIV in the mid-1990s.15
Mal-4 is a yellowish oil that is highly active and readily permeates
cell membranes and viral coat layers. Likewise, the dimethoxy and
trimethoxy derivatives are oily and active. These activities were
also observed with O-methylated cyclolignans isolated from the
same plant extract. Unlike NDGA, all these compounds were
effective at inhibiting HIV replication in cell cultures (laboratory
strains as well as primary isolates from AIDS patients).21 The
cyclolignans 30-demethoxyisoguaiacin and norisoguaiacin (Fig. 2B),
also isolated from creosote bush, were signiﬁcantly more active
than all NDGA derivatives including Mal-4.15 However, these
compounds occur in much smaller amounts in the extract
compared to NDGA and its analogs. Full synthetic methylation of
NDGA yielded the tetramethylated derivative terameprocol (M4N;
Fig. 3B), which has advanced to clinical trials as an anticancer
agent.22 M4N is an amorphous powder that naturally occurs in the
plant, but in much lower concentration than NDGA and many
NDGA derivatives.
The viral gene transcriptionmachinery of many family viruses is
made of complex structures containing a scaffold of multiple pro-
teins and transcription factors interacting with each other and with
the viral DNA to promote viral gene expression.23 Speciﬁcity Pro-
tein One (Sp1) is a crucial transcriptional regulatory element con-
trolling > 1000 genes and is found at one or several motifs in the
promoters of several family viruses. HIV contains three Sp1 motifs,
which directly and indirectly interact with the HIV Tat protein toR'
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Fig. 2. Three classes of compounds isolated from the creosote bush and contained in
the proprietary Maximum Extract 1 (Me-1) formulation: dibenzylbutanes (linear
lignans), cyclolignans, and ﬂavonoids. Within these three groups, the compounds vary
mostly in the number and positions of hydroxyl and methoxyl groups. The extract also
contains smaller amounts of saponins, sterols, tannins, and other compounds9.
Fig. 3. Important methylated lignans from creosote bush of medical relevance: Anti-
viral 30-O-methyl nordihydroguaiaretic acid (Mal-4) and anticancer tetra-O-
methylnordihydroquaiaretic acid (M4N). Other lignans isolated from the creosote
bush also possess antiviral and anticancer activities.exponentially increase the virus gene transcription and replication.
The creosote bush lignans have structural determinants that bind to
DNA sequences rich in cytosine/guanine (C/G) boxes and Sp1 is
likely to be a primary target for these compounds. The blockade of
this sequence by the plant molecules (for instance M4N) prevents
Sp1 factors from binding to their cognate site at HIV LTR promoter
level. As a result, the virus replication is abrogated. Thus, these
lignans are able speciﬁcally to inhibit HIV basal gene transcription
as well as HIV Tat-regulated gene trans-activation.21
The sexually transmitted herpes simplex virus type 2 (HSV-2)
affects ~ 500million peopleworldwide. More than 80% of theworld
population is seropositive for HSV-1 according to WHO's reports.24
Within 18 hours after infecting the cells, HSV makes three types of
genes: the immediate early or a genes, then the intermediate or b
genes and ﬁnally, the late or g genes. For a successful infection,
these genes must be made in that sequential order (a, then b, then
g). The a-gene ICP4 plays a pivotal role in this viral cascade and is an
attractive therapeutic target, since without its expression, all early
genes cannot be transcribed.25
Herpes virus has no effective vaccine but the infection can be
managed by good symptomatic drug treatments, namely nucleo-
side/nucleotide analogues. More than a dozen drugs are currently
on the market or in the pipeline of development for herpes in-
fections.26 They act as decoys that are inserted in the viral DNA
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thus temporarily suppressing the viral infection. Since these drugs
target viral DNA synthesis and the ever-changing viral enzymes,
they are prone to drug resistance in the long run.27 Acyclovir (trade
name Zovirax) has been intensively studied and is the gold stan-
dard for the treatment of HSV-1 and HSV-2.
None of the current anti-HSV drugs takes advantage of the
presence of a highly conserved therapeutic target in the virus
promoter. Indeed, the a-ICP4 promoter in all herpes simplex strains
contains 8 Sp1 binding motifs, thus providing speciﬁc targets for
the creosote bush lignans. Several studies have shown that NDGA
derivatives suppress HSV infection in vitro and in vivo, with no
indication of cytotoxicity or drug resistance. In fact, in a compara-
tive study between acyclovir and M4N in acyclovir-resistant HSV
strains, M4N was able to inhibit all acyclovir-resistant HSV strains
to the 10th passage (ﬁnal endpoint) in Vero cells while inducing
virtually no intrinsic cytotoxicity.28 As a result, the spread of genital
herpes infections, which is nowa factor in the spread of HIV/AIDS,29
and other sexually transmitted diseases including papilloma virus
infection, could signiﬁcantly be curbed worldwide.
Human papillomavirus (HPV) causes uncontrolled cell prolifera-
tion and uterine cervical intraepithelial neoplasia, which may
become cancerous. According to a recent report of the WHO, each
year 530,000 women develop cervical cancer and about 275,000
(52%) die from the disease. DNA sequencing of HPV genome shows
that virus has more than 200 types. To our knowledge, no effective
drug treatmentofHPVhasbeen reportedyet.However, commercially
available vaccines against the most virulent HPV types are currently
in clinical use.Molecular studies show that all HPV types contain one
Sp1motif in theirHPV-16 long control regionpromoter,whichmakes
thema speciﬁc target for the creosote bush lignans. Indeed,Mal-4 has
been shown to interfere with HPV type 16 early promoter p97 to
suppressHPV replicationvia interactionwith Sp1 transcription factor
in p97 promoter.30 These and other in vitro studies on the anti-HPV
activities of the plant lignans are corroborated by conclusive pre-
clinical and clinical studies of terameprocol on the cervix of women
for potential use of the drug as a microbicide.31,32
In summary, herpes viruses have a wide range of drug treat-
ments but no vaccine. Human papillomavirus has vaccines but no
drug treatment. The creosote bush lignans indiscriminately sup-
press the infections of both viruses. Therefore, the plant lignans
inhibit the replication of at least three major sexually transmitted
viruses (HIV, HPV, and HSV) by blocking the invariable Sp1 gene
transcription cofactor that they share in common. This unique
feature makes these plant molecules potential agents in a useful
vaginal microbicide to stop sexual exposure to these viruses. It is
noteworthy that beside these three viruses, Sp1 motifs are found in
the viral gene promoters of a number of other viruses including
blindness-causing cytomegalovirus and the potential tumor-
causing simian vacuolating virus 40. Other newly emerging vi-
ruses may be responsive to these lignans as well.
6.2.2. Anticancer activities
Carcinogenesis is a multistage event affected by a variety of
genetic and epigenetic factors and is typiﬁed by the outbreak of
uncontrolled cell growth originated from different tissues. A uni-
versal goal for anticancer research lies in the development of a
clinical treatment that must meet three criteria: (1) the drug must
be highly effective in curtailing tumor growth; (2) it must be
nontoxic to the host; and (3) it must be affordable for most patients.
Drugs that inhibit targets that are unique to dividing cells, partic-
ularly cells in an uncontrolled division, are an ideal paradigm for
chemotherapeutic agents. The greater the speciﬁcity to cells that
are dividing in an uncontrolled manner, the lower the risks of
attendant side effects.In addition to its antiviral activities, M4N has proved to be an
effective anticancer agent.33 Structural binding studies using a wa-
ter soluble M4N analog have demonstrated that it interacts with G
and C residues within the Sp1 consensus binding site (unpublished
nuclear magnetic resonance data) resulting in a widening of the
major groove of the DNA double helix and inhibition of Sp1 binding
as demonstrated by crystallographic studies.34 Preclinical studies
have demonstrated that M4N suppresses the growth of a variety of
mouse and human tumor cells and human tumor explants in nude
mice.35 Cancer cell growth retardation and cytotoxicitywere shown
to be in part the result of terameprocol's ability to block transcrip-
tion of the Sp1-dependent genes CDC2 and surviving, leading to cell
cycle arrest and apoptotic death of the tumor cells.36,37 M4N is
currently in clinical trials and has been found safe for human use.38
Tumor cells often become resistant to chemotherapy that was
initially effective. One mechanism of drug resistance that has been
described is over-expression of the multiple drug resistance gene
(ABCB1) encoding a transmembrane glycoprotein (P-glycoprotein).
This protein is one of a family of proteins involved in plasma
membrane permeability that function as efﬂux pumps for
numerous lipophilic anticancer drugs.39 The P-gp/MDR1 protein is
over-expressed in drug resistant neoplastic cells and its gene pro-
moter is regulated by the Sp1 transcription factor, which is an
oncogenic factor.40 Methylated NDGA derivatives have been shown
to induce a reversal of multidrug resistance of breast cancer cells to
doxorubin or paclitaxel, key chemiotherapeutic agents of the
deadly disease.33
In summary, the molecular mechanisms underlying the anti-
cancer activities of creosote bush lignans have been shown to
involve a dozen cancer pathways, and this number is on the rise as
research progresses. The speciﬁc inhibition of the nonmutable Sp1
oncogenic factor and all the mechanisms under its control
including the drug resistance efﬂux pump, along with the relative
non-toxicity of these plant lignans, represent key factors that make
the creosote bush molecules of important clinical relevance for the
treatment and prevention of current and future diseases.
6.2.3. Activity against neurodegenerative disorders and senescence
The activities of the plant lignans against neurodegenerative
disorders and aging symptoms are crucial since these disorders
have taken a heavy toll on industrial nations with long living
populations. The detailed studies will be published elsewhere, but
here we summarize the recent data on these lignans.
As dreadful as cancer is, the disease is not always caused by
genomic instability or family inheritance of abnormal genes, which
contributes to < 10% of carcinogenesis. About 90% of all cancers
result from risk factors, namely environmental factors and life-
style.41 These risk factors are: cigarette smoke, alcoholic beverages,
environmental pollutants (pesticides, gasoline exhausts, industrial
pollutants), sun UV sunlight, food (fried, grilled, smoked), red meat
consumption, cancer-causing infectious agents (HIV, HPV, Heli-
cobacter pylori, hepatitis B virus, hepatitis C virus, etc.), stress,
obesity, hyperglycemia, lack of physical exercises, etc. The link be-
tween these risk factors and cancer promotion is the production of
proinﬂammatorymediators such as cytokines, chemokines, reactive
oxygen species, and inﬂammatory enzymes.42 It is established that
most of these risk factors are also etiological for neurodegenerative
disorders and premature ageing of human brain cells. Reactive ox-
ygen species are now directly implicated in a variety of neurological
disorders including cerebral ischemia, Alzheimer's disease, accel-
eration of neuronal senescence, and loss of brain cells.43
The creosote bush lignans have been known for decades for
their strong anti-inﬂammatory activities. They block the produc-
tion of these proinﬂammatory mediators by inhibiting the enzymes
responsible for the inﬂammatory cascades.44 This partially
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type II diabetes,45 rheumatoid arthritis, vascular diseases,46 etc.,
and their remarkable neuroprotective effects were recently
described in an excellent review.14 Increasing data also support the
beneﬁcial effects of the plant lignans against Alzheimer's disease
and retardation of senescence (aging symptoms), as Miller and his
team47,48 demonstrated on animal models of the disease.
All these multifaceted activities of the plant lignans justify the
various medicinal applications of the creosote bush extract in the
traditional sphere. It is our postulate that these plant lignans along
with their ﬂavonoid congeners (also active), could represent an
important natural cocktail for the treatment of major human ail-
ments such as viral infections, cancer, and neurodegenerative dis-
eases, as the ethnobotanical data have shown for decades among
indigenous populations.
7. A lignan-ﬂavanoid combination cocktail for the treatment
of cancers and viruses
Targeted therapy of cancer has proved beneﬁcial and has saved
countless lives, but the cure rate remains ~ 25%. This translates to aFig. 4. (A) Flash chromatography of creosote bush total extract to remove the bulk of volatile
plant toxicity (personal communication). (B) Countercurrent chromatographic (CCC) puriﬁc
the semipuriﬁed extract was ﬁrst established. Active peaks were pooled into two majors frac
studies are published elsewhere.15 All compounds were characterized by nuclear magneti
cyclolignans, several ﬂavonoids and all linear lignans without NDGA, the cyclolignans, and se
blue capsules by a proprietary pharmaceutical capsule formulation after animal studies fo
inactive ingredients of capsule formulation. The blue capsules demonstrated greater efﬁcac75% failure rate. Because cancer cells are continually undergoing
genetic changes, cancer eradication will require a multitargeted
approach to inhibit all of the biological pathways involved. Simi-
larly, it is now established that for an effective control of HIV/AIDS,
a combination of antiretroviral drugs is required to suppress virus
replication in patients. A combination of the creosote bush com-
pounds differs from established drug regimens for cancer and virus
infections, since the plant molecules are relatively safe, have syn-
ergistic effects, and circumvent the development of drug resistance.
We show in this review that a combination of lignans and ﬂavo-
noids of the creosote bush may represent a safe and effective asset
from nature to combat these diseases.
The Maximum Extract 1 (Me-1) formulation (Fig. 4C) is a new
strategy based on principles of traditional medicine and modern
targeted therapy. Plant lignans and ﬂavonoids suppress a signiﬁcant
number of cancer pathways. In addition, lignans inhibit the multi-
drug resistant efﬂux pump, and thus potentiate most anticancer
agents as well as other phytochemicals. The combined action of the
lignans and ﬂavonoids appears to be synergistic, eliciting much
greater activity than when one class of compounds is used alone.
The clinical use of creosote bush extract is not new. One of the mostcompounds (dark band eluting with solvent front), which is mainly responsible for the
ation of active components of the detoxiﬁed extract. A chromatographic ﬁngerprint of
tions (Gr and Lo) based on their TLC patterns, and further resolved by CCC. The isolation
c resonance and mass spectrometry. As shown on Fig. 2, Me-1 formulation contains
veral ﬂavonoids, as shown on Fig. 2 (C) Blue capsules. Me-1 extract was formulated into
r safety (Table 1). This ﬁnal product encompasses all compounds of Fig. 2, including
y than any individual lignan when tested on humans as a dietary supplement.
Table 1
Toxicity testing of the Maximum Extract 1 (Me-1) formulation on animals. The
puriﬁed Me-1 was formulated to be included in the animal feed and submitted to a
month-long acute toxicity studies on rats (about 300 g females). The animals were
divided into four groups of four animals/cage. The rats in the ﬁrst cage received no
drug in their feed (placebo). Rats in the second cage were given a dose of Me-1 ﬁve
times ( 5) the equivalent of the human dose (200mg for a 70 kg person). Rats in the
remaining two cages received 15 times ( 15) and 50 times ( 50) the equivalent of
the human dose, respectively. All the animals were fed for 28 days with Me-1
product under identical conditions as the placebo group. At the end of the study,
the animals were sacriﬁced and all blood parameters, liver enzymes, and histology of
the major organs were analyzed by state-of-the-art methods. There was no statis-
tically signiﬁcant difference between the drug-treated groups and the placebo,
neither was any signiﬁcant difference found among the drug-treated groups. Me-1
was then formulated into blue capsules using a proprietary pharmaceutical method
of capsule formulation.
Drug Dose (in feed daily
for 1 mo)
Toxicity (compared
to placebo)
Placebo (No Me-1) 0 mg
Me-1 ( 5) 4.3 mg No signiﬁcant difference
Me-1 ( 15) 12.9 mg No signiﬁcant difference
Me-1 ( 50) 42.9 No signiﬁcant difference
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in tea and in tincture. Chaparral has been evaluated in clinical
studies for intrinsic toxicity49 as well as for anticancer activities.50
The conclusion of these studies emphasized a potential liver
toxicity of chaparralwhen used in a high dose,51which, according to
our ﬁndings, is due to a signiﬁcant presence of essential oils.
Our studies also showed that chaparral tea and tincture contain
only 10% and 25%, respectively of the active methylated lignans in
the total extract. To develop a cocktail of the beneﬁcial natural
products of the creosote bush, the extract of the plant leaves was
ﬁrst detoxiﬁed by ﬂash silica gel column chromatography to
remove the essential oils (Fig. 4A). The semipuriﬁed extract (called
Me-1) was analyzed using countercurrent chromatography (CCC),
and a reference ﬁngerprint chromatogram of the extract was
established. Thin-layer chromatography analysis enabled the
identiﬁcation of all the peaks of anti-HIV active lignans in two pools
(Gr and Lo), which were individually resolved based on the sepa-
ration conditions of our previous study.15 (An example of the pu-
riﬁcation of Lo fraction is illustrated in Fig. 4B.) The cocktail of Me-1
was generated by gathering all the compounds resulting from the
separation studies, and after their chemical characterization by
nuclear magnetic resonance and mass spectrometry. As shown in
Fig. 2, Me-1 consists mostly of three classes of compounds: (1) the
11 dibenzylbutane lignans (without NDGA but including M4N and
Mal-4); (2) the ﬁve very active cyclolignans; and (3) several ﬂavo-
noids including quercetin, luteolin, and methylated ﬂavonoids such
as ayanin, devoid of anti-HIV activity, were included into the
formulation for their anticancer effects.
Interestingly, most compounds in Me-1 formulation have
various degrees of methylation. Methylated molecules are more
lipophilic, and therefore can more readily permeate lipid bilayer
cell membranes and virus envelope to disrupt the targeted mech-
anisms inside. All these compounds should work synergistically as
they compete for various targets inside the cells and viruses. It is
our view that for a robust and effective treatment of complex dis-
eases such as cancer, a combination of small organic molecules is
required, and these molecules must fulﬁll three major criteria: (1)
they must be relatively safe, sparing normal cells and reversing
multidrug resistance phenotype of cancer cells; (2) they must have
multi-ligand capability, i.e., each molecule in the cocktail must act
on multiple biomolecular targets; and, ﬁnally, (3) they must be
capable of reversing tumorigenesis by inhibiting oncogenes or
restoring the tumor suppressor genes such as the p53 family of
tumor suppressor proteins. It is our hypothesis that Me-1 formu-
lation meets all these requirements, and thus should be a com-
plement to current chemotherapy, or a valid alternative to cancer
treatment.
As for safety, Me-1 was formulated into oral capsules after
toxicity testing in animals showed that the product was devoid of
acute toxicity (Table 1). The United States Food and Drug Admin-
istration, which audited the studies, gave their stamp of approval
for safety of the formulation. The bioassays showed that the cock-
tail was signiﬁcantly more active than each major NDGA derivative
(M4N, Mal-4), when tested against various cancer cell lines (data
not shown). This activity was even greater by several hundred-fold
in in vivo studies. These results were corroborated by other in-
vestigators who demonstrated that organic extracts of the creosote
bush exhibited greater activity than individual compounds
including NDGA and the cancer drug paclitaxel when tested against
breast cancer cell lines (MCF7).52 These preliminary results lend
validity to our view that the Me-1 strategy may lead to a safer and
more effective anticancer and antiviral cocktail. This formulation
may be a bridge between Eastern herbal-based medicines and
Western single synthetic molecule-based chemotherapy. Since
Western medicine has begun to embrace the use of drugcombinations, we postulate that our Me-1 formulation may
represent the trend of future medicines for complex diseases.8. Conclusion and perspectives
The accumulated scientiﬁc data on creosote bush lignans lend
credentials to the multi-faceted uses of the plant in the traditional
sphere. These plant products are especially effective against viral
diseases and cancer. For millennia, the creosote bush has served as
an important source for folk medicine to several indigenous pop-
ulations of South and North America. Only in the past few decades
has the ethnopharmacological history of the plant generated
considerable interest for investigations of the active principles
responsible for the multipurpose uses of the plant in traditional
medicine.
Viruses such as HIV, HSV, inﬂuenza viruses, and cold viruses
infect and kill millions of people every year. Severe acute respira-
tory syndrome, avian ﬂu viruses, Middle East respiratory syndrome
corona virus, Ebola virus, and many others are still without treat-
ments and some may become global pandemics if not urgently
addressed. The few vaccines available against some of these viruses
need to be updated every year, and never reach the majority of
people in developing nations. Antibiotics are designed to reach and
stop the replication of bacteria without crippling the vital cellular
genetic machinery. By contrast, most viruses have the ability to
hijack the cell genetic machinery inside the nucleus in order to
replicate. This explains why antibiotics are often ineffective against
many viral infections such as the ﬂu, cold virus, and many others.
The creosote bush lignans possess the ability to act at the cellular
level and permeate the nucleus and the virus envelope to block the
viral gene machinery.21 They are capable of suppressing viruses
that contain Sp1 or are rich in C/G boxes in their gene transcrip-
tional machinery such as HSV, varicella zoster virus, blindness-
causing cytomegalovirus, HIV, and HPV. Since Sp1 and C/G motifs
are common features in many virus families and are highly
conserved (nonmutable), this class of plant lignans could represent
a breakthrough for viral treatment as penicillin became for bacteria
since World War II.
In this review, we presented the most recent ﬁndings on the
active ingredients of the creosote bush, especially the lignans. We
showed that the use of these compounds to treat and prevent
modern diseases, some of which have no cure, demonstrates the
relevance of traditional medicine as a pathﬁnder to the search for
J. Gnabre et al. / Journal of Traditional and Complementary Medicine 5 (2015) 119e126126molecules with new applications. Since the current diseases are
complex and involve multiple pathways, a cocktail of safe but
effective molecules is the best strategy to defeat these diseases.
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